chr1-161223055-CCACACA-C
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BA1
The ENST00000367990.7(APOA2):c.53-11_53-6delTGTGTG variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.32 ( 7601 hom., cov: 0)
Exomes 𝑓: 0.26 ( 2653 hom. )
Failed GnomAD Quality Control
Consequence
APOA2
ENST00000367990.7 splice_region, intron
ENST00000367990.7 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.116
Genes affected
APOA2 (HGNC:601): (apolipoprotein A2) This gene encodes apolipoprotein (apo-) A-II, which is the second most abundant protein of the high density lipoprotein particles. The protein is found in plasma as a monomer, homodimer, or heterodimer with apolipoprotein D. Defects in this gene may result in apolipoprotein A-II deficiency or hypercholesterolemia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 1-161223055-CCACACA-C is Benign according to our data. Variant chr1-161223055-CCACACA-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 293295.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Uncertain_significance=1}. Variant chr1-161223055-CCACACA-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.384 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APOA2 | NM_001643.2 | c.53-11_53-6delTGTGTG | splice_region_variant, intron_variant | ENST00000367990.7 | NP_001634.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APOA2 | ENST00000367990.7 | c.53-11_53-6delTGTGTG | splice_region_variant, intron_variant | 1 | NM_001643.2 | ENSP00000356969.3 | ||||
APOA2 | ENST00000470459.6 | c.53-11_53-6delTGTGTG | splice_region_variant, intron_variant | 5 | ENSP00000477031.1 |
Frequencies
GnomAD3 genomes AF: 0.323 AC: 47590AN: 147306Hom.: 7589 Cov.: 0
GnomAD3 genomes
AF:
AC:
47590
AN:
147306
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.282 AC: 55088AN: 195520Hom.: 1084 AF XY: 0.283 AC XY: 30133AN XY: 106664
GnomAD3 exomes
AF:
AC:
55088
AN:
195520
Hom.:
AF XY:
AC XY:
30133
AN XY:
106664
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.264 AC: 378883AN: 1435404Hom.: 2653 AF XY: 0.264 AC XY: 188776AN XY: 713980
GnomAD4 exome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
AC:
378883
AN:
1435404
Hom.:
AF XY:
AC XY:
188776
AN XY:
713980
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.323 AC: 47636AN: 147418Hom.: 7601 Cov.: 0 AF XY: 0.327 AC XY: 23426AN XY: 71626
GnomAD4 genome
AF:
AC:
47636
AN:
147418
Hom.:
Cov.:
0
AF XY:
AC XY:
23426
AN XY:
71626
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Apolipoprotein A-II deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 12, 2019 | - - |
APOA2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 28, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at